A study of association between expression of hOGG1, VDAC1, HK-2 and cervical carcinoma by Guo-Qing, Peng et al.
RESEARCH Open Access
A study of association between expression of
hOGG1, VDAC1, HK-2 and cervical carcinoma
Peng Guo-Qing
1,2, Yang Yuan
2,3*, Zhong Cai-Gao
3, Yin Hongling
4, Hu Gonghua
3, Tian Yan
1*
Abstract
Background: Human 8-oguanine glycosylase 1(hOGG1), voltage-dependent anion channel 1(VDAC1), hexokinase 2
(HK-2), represented the process of oxidative DNA damage, cell apoptosis and glycolysis, respectively. This study
aims to explore the association between expression of hOGG1, VDAC1, HK-2 and cervical carcinoma.
Methods: A case-control study was conducted. 65 cervical biopsy samples consist of 20 control and 45 cases. The
expression of hOGG1, VDAC1 and HK-2 were examined with immunohistochemistry(IHC), immunolabeling was
evaluated with stereological cell counts.
Results: The data showed that the positive proportion of hOGG1 and HK-2 in the case group was higher than that
of the control group (P < 0.05). Further, there was an increasing trend for the positive proportion and expression
degree of hOGG1 and HK-2 from Control, Mild cervical carcinoma (MCC), Intermediate cervical carcinoma(ICC) to
Severe cervical carcinoma(SCC) in order (P < 0.05). To VDAC1, the significant result was not obtained.
Conclusions: The results suggested that there was a close association between expression of hOGG1, HK-2 and
cervical cancer. hOGG1 and HK-2 might play a key role at the early stage of cervical cancer, and the findings of
hOGG1 and HK-2 should be considered as a significant biomarker at the early stage of cervical cancer.
Background
Cervical cancer is currently one of the most frequently
occurring cancer among women[1]. In China, Sample
surveys showed that Cervical cancer is the major cause
of death in women, the proportion of death rank in the
fourth place, only behind gastric carcinoma, esophageal
carcinoma, hepatic carcinoma[2]. Furthermore, the age
range of cervical cancer incidence become more and
more younger since the past 30 years[3-5]. At the pre-
sent, researchers considered cervical cancer as a disease
which is impacted by many factors, and these factors
was classified as environment cause or genetic factors,
Such as infection of human papilloma virus(HPV) and
human immunodeficiency virus(HIV), ill behavior of
sex, smoking, chromosome deficiency, Single Nucleotide
Polymorphism(SNP), etc[6-8]. Prevention of cervical
cancer is still an unsettled puzzle. At the present, early-
stage cervical cancer could be detected mainly by cyto-
logical screening of papanicolaou smear test and patho-
logical diagnosis of cervical biopsy sampling. To cervical
cancer, the mainly method of therapy were still surgical,
chemical and radialion therapy. The result of treatment
depended on early discovering of cervical carcinoma in
great degree.
In recent study, some abnormal molecular biology
changes are considered playing a central role in process
of cervical cancer and cervical precancerous lesion. And
these biomarkers of abnormal molecule can be used to
forecast the incidence probability of cervical precancer-
ous lesions. Consequently, the patient condition of early
discovering will be improved obviously through earlier
therapy. In recent years, many significant study findings
were obtained, for example, study of Reddy VG et al
[9,10]showed that telomerase activity was detected in
96.5% of cervical tumor samples and in 68.7% of prema-
lignant cervical scrapings but was not detected in con-
trol hysterectomy samples and in cervical scrapings of
normal healthy controls. The absence of telomerase
activity in cervical scrapes from healthy women indi-
cated the potential of telomerase to serve as a good
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cer. Murphy N et al[11,12] found that p16INK4A
expression was closely associated with high risk HPV
infection, all grades of squamous and glandular cervical
lesions were IHC positive, p16INK4A was the most reli-
able marker of cervical dysplasia.
Generally, oxidative DNA damage, cell apoptosis, gly-
colysis were considered playing a essential role in the
dynamic process of neoplasm. Many environmental fac-
tors could induce production of oxidative DNA damage,
and further continual evolution, the following result was
genetic mutation, dysfunction of cell cycle, apoptosis.
Majority of normal cell died in the form of apoptosis,
and minority of abnormal cell survived yet and grew
unlimited. Ultimately, abnormal cell is stimulated and
activated in the form of neoplasm cell. Furthermore, Its
mainly mode of energy production was glycolysis meta-
bolism[13-15]. Our current question is, did the similar
physiological course of malignant transformation occur
also in the transformation process from normal cervical
tissue to cervical cancer? At present, relatively study is
documented rarely about the combined feature of oxida-
tive DNA damage, cell apoptosis, glycolysis in cervical
cancer tissue. Therefore, we selected three genes[16-18],
Human 8-oguanine Glycosylase 1(hOGG1), voltage-
dependent anion channel 1(VDAC1), hexokinase 2(HK-
2), represented the process of oxidative DNA damage,
cell apoptosis, glycolysis, respectively. And the expres-
sion of hOGG1, VDAC1, HK-2 were detected by the
method of IHC for exploring the association between
them and cervical cancer.
Materials and methods
Tissues samples
65 paraffin wax-embedded cervical biopsy samples were
selected from the pathology department of the Xiangya
Hospital, Central-South University. These samples were
divided into two groups containing 20 control and 45
cases, and 45 cases of cervical cancer including 15 mild,
17 intermediate, 13 severe according to pathological
diagnosis. Haematoxylin and eosin stained slides of all
biopsy samples were reviewed by two pathologists and
classified according to criteria outlined by the World
Health Organization (WHO). Ethical approval for use of
all specimens was obtained from the research ethics
committee of the Xiangya Hospital.
Antibodies
Available Rabbit anti-Human polyclonal antibody HK-2
was from Abnova, USA; 8-oxoguanine DNA Glycosy-
lase Homolog 1 (OGG1) and Voltage-Dependent
Anion Channel 1 (VDAC1) Rabbit anti-Human Poly-
clonal Antibody were all from LifeSpan BioSciences,
USA.
IHC on biopsy samples
Sections (4 μm thick) were cut from paraffin wax
embedded biopsy samples and mounted on 3-aminopro-
plytriethoxysilane coated glass slides. Sections were
dewaxed by passage through xylene and then rehydrated
in graded alcohol. Endogenous peroxidase activity was
blocked by incubating the sections in 3% H2O2 for 10
minutes. Antigen retrieval was performed in 0.01 M
citrate buffer (pH 6.0) using high pressure cooker for 15
minutes. After washing sections in Phosphate Buffered
Saline(PBS, pH 7.4), non-specific antibody binding was
reduced by incubating the sections in 10% normal goat
serum for 15 minutes. After decanting excess serum,
sections were incubated overnight at 4°C with primary
rabbit anti-human polyclonal antibody HK-2 (1:50 dilu-
tion), OGG1 (1:100 dilution), or VDAC1 (1:500 dilu-
tion). Sections were washed three times for 5 minutes at
the following day, respectively. Adding polymer enhan-
cer 50 ul and incubating for 20 minutes, repeating pre-
vious washing method. After washing thoroughly with
PBS, the sections were incubated for 20 minutes with
secondary antibody horseradish peroxidase(HRP)-poly-
mer anti-goat IgG at room temperature. The avidin-per-
oxidase protocol (ABC Kit-5020; Abnova) was applied in
the last step of the procedure, using 3, 3-diaminobenzi-
dine(Sigma, St. Louis, MO, USA) as chromogen. The
sections were counterstained lightly with haematoxylin.
Finally, the sections were dehydrated, cleared, cover-
slipped. Controls were carried out with the same proto-
cols but omitting the primary antibodies, which did not
result in any staining.
Statistical analysis
The results of experiment was collected by computer,
the process of data analysis was carried out by Microsoft
office Excel 2003 and SPSS13.0. The Pearson Chi-Square
(c
2) test was used to compare difference between two
groups. The development trend of CIN was evaluated by
the method of Linear c
2 test. The McNemar c
2 and
Kappa statistic were used to analyze consistency level
between hOGG1 and VDAC1 or HK-2. A 0.05 P-value
of two-sided test was the standard of statistics signifi-
cant. For the sake of statistical convenience, the positive
results of ±,+,++ and +++ were merged into one group.
Results
IHC staining of hOGG1, VDAC1, HK-2
All staining sections were conserved in the form of pic-
tures. The pictures showed that hOGG1 and HK-2
located in cervical epithelial tissue or glands or cytoplasm
of cervical biopsy samples, VDAC1 located in cervical
epithelial tissue or glands or cell membrane of cervical
biopsy samples. The positive result of staining was yellow
or brown yellow. The map of expression of hOGG1,
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Page 2 of 6VDAC1, HK-2 was listed partially (Figure 1). The result
of positive or negative was diagnosed by the method of
stereological cell counts. The absence of positive cell was
indicative of negative(-). when observed positive cell was
less than 25 percent, the result of diagnosis was slightly
positive(±). when the proportion of positive cell ranged
from 25 to 50 Percent, the result of diagnosis was posi-
tive(+). When more than 50 percent of positive cell was
observed, we considered it intense positive (++).
Expression of hOGG1, VDAC1, HK-2 in cervical biopsy
samples
We compared the positive proportion of hOGG1,
VDAC1, HK-2 between control and case group, the
table 1 showed that there were a significant difference
for hOGG1, HK-2 between two groups. To VDAC1, the
difference was not obviously significant. More detail in
Table 1 and Figure 2.
Further, we analyzed the divided Cases samples
according to pathology diagnosis for more valuable
information. As described in the Table 2, Figure 3, the
proportion of positive expression of hOGG1 and HK-2
showed an increasing trend from Control, MCC, ICC to
SCC in order. To VDAC1, the increasing trend of posi-
tive proportion was not observed.
Comparison of consistency level of hOGG1, VDAC1 and
HK-2
In order to observe the consistency of expression
hOGG1, VDAC1 and HK-2, Pair c
2 test and Kappa
Figure 1 The expression of hOGG1, VDAC1, HK-2 was displayed by figure a,b,c,d,e,f in turn, figure a,c,e were representative of
negative expression, while figure b,d,f were indicative of positive expression, respectively.
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pairs of hOGG1–VDAC1, hOGG1–HK-2, VDAC–HK-2.
As showed in the Table 3, Overall, there was a low level
of consistency expression in pairs of hOGG1–VDAC1,
VDAC–HK-2 and hOGG1–HK-2.
Relationship between expression degree of hOGG1,
VDAC1, HK-2 and classified cervical biopsy samples
65 cervical biopsy samples were classified as -, ±, + and
+ +f o u rt y p e so rC o n t r o l ,M C C ,I C Ca n dS C Cf o u r
groups according to proportion of positive cell or
pathology diagnosis. As a result, we observed that rela-
tionship between expression of hOGG1, VDAC1, HK-2
and graded pathology types of cervical biopsy tissue. As
showed in Table 4, there was an increasing trend for the
expression degree of hOGG1 and HK-2 from Control,
MCC, ICC to SCC in order. To VDAC1, This trend of
statistical significance was not observed.
Discussion
Cervical cancer is the secondary frequently occurring
carcinoma among women. Its incidence rate is from
3.25-10.28 per 100000 approximately in china, lower
only than breast neoplasm[8]. Generally, people consider
that cervical cancer is a disease activated by many fac-
tors, the dynamic mechanism of Cervical cancer is not
yet elucidated completely due to the complexity of
pathogeny evolvement pathway. In the same way, the
screening of early and sensitive biomarker is also an
unsettled problem. Furthermore, cervical cancer is asso-
ciated closely with oxidative DNA damage, cell apopto-
sis, glycolysis. To explore the unsettled puzzle, develop
more significant biomarker of cervical cancer and cervi-
cal precancerous lesions, we analyzed the expression of
hOGG1, VDAC1 and HK-2 in cervical biopsy tissue.
The following result was exhibited orderly.
① T h er e s u l to fe x p e r i m e n ts h o w e dt h a tt h ep o s i t i v e
proportion of hOGG1 and HK-2 in the case group was
higher than that of the control group (P < 0.05), there
was no obvious differentiation for positive proportion of
VDAC1 in the case group and the control group; ②
Further, statistical analysis showed that there was an
increasing trend for the positive proportion of hOGG1
and HK-2 from Control, MCC, ICC to SCC in order.
To VDAC1, the increasing trend of positive proportion
was not observed; ③ Consistent pair study showed that
there were a lowly level of consistency expression in
pairs of hOGG1–VDAC1, VDAC1–HK-2 and hOGG1–
H K - 2 .T h er a n g eo fK a p p av a l u ew a sf r o m0 . 0 5 9t o
0.316. The result indicated that there was no interaction
effect in pairs of hOGG1–VDAC1, VDAC1–HK-2 and
Table 1 Distribution of expression of hOGG1, VDAC1,
HK-2 in control and case
groups n hOGG1 VDAC1 HK-2
- + +% - + +% - + +%
Control 20 17 3 15.0 5 15 75.0 12 8 40.0
Case 45 10 35 77.8 5 40 88.9 10 35 77.8
total 65 27 38 58.5 10 55 84.6 22 43 66.2
c
2 22.47 1.12 8.83
P 0.000 0.289 0.003
Note: P value of c
2 is indicative of result of comparison between control and
Cases, When P value is below standard of 0.05, the level of difference is
significant.
Figure 2 Distribution of expression of hOGG1, VDAC1, HK-2 in
control and case.
Table 2 Expression of hOGG1, VDAC1, HK-2 in classified
cervical biopsy samples
hOGG1 VDAC1 HK-2
- + +% - + +% - + +%
Control 17 3 15.0 5 15 75.0 12 8 40.0
MCC 6 9 60.0 1 14 93.3 4 11 73.3
ICC 3 14 82.4 3 14 82.4 2 15 88.2
SCC 1 12 92.3 1 12 92.3 4 9 69.2
Linear c
2 23.295 1.171 5.207
P 0.000 0.279 0.023
Note: MCC, ICC and SCC were explained in abbreviations, Linear c
2 was used
to analyze trend of expression from control, MCC, ICC to SCC in order. When
P < 0.05, the trend is significant.
Figure 3 Expression of hOGG1, VDAC1, HK-2 in classified
cervical biopsy samples.
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Page 4 of 6hOGG1–HK-2; ④ In addition, we observed that relation-
ship between expression degree of hOGG1, VDAC1,
HK-2 and graded pathology types of cervical biopsy tis-
sue. The result indicated that there was an increasing
trend for the expression degree of hOGG1 and HK-2
from Control, MCC, ICC to SCC in order. To VDAC1,
the significant trend was not observed.
The above description indicated that there was close
association between expression of hOGG1, HK-2 and
Cervical cancer. hOGG1 was one of glycosylases in the
base excision repair (BER) system, played a central role
in removing adducts from oxidative DNA damage,
which was nominated by 8-Oxo-7,8-dihydroguanine (8-
oxoGua)[16]. When DNA repair system of the organism
is normal, the expression level of hOGG1 can reflect
indirectly accumulated level of 8-oxoGua in organism.
Therefore, we combined the result of higher positive
proportion of hOGG1 in the case group with an increas-
ing trend for the positive proportion of hOGG1 from
Control, MCC, ICC to SCC in order. We could draw a
conclusion that oxidative DNA damage existed in early
stage of cervical cancer, the increasing expression degree
of hOGG1 reflected severity of oxidative DNA damage
in the progress of cervical cancer and the precancerous
lesions. Our hypothesis was that many outside factors
can induce the production of irritative oxidative reac-
tion, further, it produced excessive reactive oxygen
species(ROS) and attacked cell nucleus DNA, resulting
in an increasing level of accumulated 8-oxoGua. 8-oxo-
Gua is an abnormal DNA base. Which has capacity of
inducing gene mutation and neoplasm[19]. As a result,
we proposed that oxidative DNA damage was probably
one of dynamical mechanism of cervical cancer. The
level of oxidative DNA damage can be reflected indir-
ectly by DNA repair gene hOGG1. Therefore, maybe
hOGG1 play a crucial role at early stage of cervical can-
cer, and detection of hOGG1 is valuable for the early
discovering of cervical cancer.
Our experiment proved that HK-2 was associated with
cervical cancer as well. HK-2 is one of crucial enzyme
involved in the conversion of hexose phosphate in path-
way of cell glycolysis. While cell be in the case of mito-
chondria dysfunction, glycolysis reaction is activated to
produce ATP for compensating the supply of energy of
cell survival and growth. But the method of through gly-
colysis pathway is not an effective way of ATP produc-
tion, which is one condition of abnormal energy supply.
As a result, it can influence normal condition of cell dif-
ferentiation and Cell proliferations, and finally constitu-
tes the underlying basis of neoplasm cell [20]. Some
experiments testified that HK-2 is binding to mitochon-
dria in carcinoma tissue, such mode of binding is help-
ful for HK-2 making use of energy produced by
mitochondria[21]. Other study discovered also that HK-
2 was adhered to outer mitochondrial membrane
(OMM), and interacted with VDAC1 executing anti-
apoptosis effect[22,23]. Therefore, on the one hand the
expression of HK-2 could reflect level of glycolysis, on
the other hand it reflected a lower level of cell death as
well. Our experiment proved that the positive propor-
tion and level of expression of HK-2 showed an increas-
ing trend along the progress of cervical cancer. Such
result indicated that energy mechanism of glycolysis
existed in early stage of cervical cancer, and when cervi-
cal neoplasm progressed forward in irreversible way,
level of glycolysis in cell was increasing correspondingly,
and level of cell death is decreasing at the same time.
As a result, we proposed considerately that HK-2 should
be considered as a significant biomarker at the early
stage of cervical cancer and the cervical precancerous
lesions. Further, the degree of expression of HK-2 could
reflect the degree of neoplasm tissue transformation
malignant. In addition, the consistency experiment
showed that no statistical significant interaction was
observed between HK-2 and VDAC1, further study was
essential for discovering more valuable information.
Abbreviations
CIN: cervical intraepithelial neoplasia; hOGG1: human 8-oguanine glycosylase
1; VDAC1: voltage-dependent anion channel 1; HK-2: hexokinase 2; MCC:
mild cervical carcinoma including CINIand CINII; ICC: intermediate cervical
Table 3 The consistency level of expression of hOGG1,
VDAC1, HK-2 in cervical samples
VDAC1 HK-2 HK-2
-+-+ -+
hOGG1 - 5 22 14 13 VDAC1 - 5 4
+ 5 33 8 30 + 17 39
c
2 9.48 0.76 6.86
P 0.002 0.383 0.007
Kappa 0.059 0.316 0.157
Note: Pair c
2 or McNemarc
2 is used to analyze consistency level commonly,
When P < 0.05, the consistency level is not significant. Similarly, When Kappa
< 0.45, indicating a low consistency level.
Table 4 Relationship between expression degree of
hOGG1, VDAC1, HK-2 and pathology types
hOGG1 VDAC1 HK-2
- ±++ +-±+ + +- ±++ +
Control 17 3 0 0 5 1 10 4 12 4 4 0
M C C6 540 107 7 4 542
I C C 3 077 337 4 2 591
S C C 1 174 137 2 4 351
c
2 33.54 0.049 8.358
P 0.000 0.825 0.004
Note: The c
2 was used to analyze the bidirectional trend of hOGG1, VDAC1
and HK-2, When P < 0.05, the trend was significant.
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